Latest News and Press Releases
Want to stay updated on the latest news?
-
Vancouver, B.C., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, October 8, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announces that,...
-
Vancouver, B.C., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, September 24, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) the...
-
Vancouver, B.C., Sept. 20, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, September 20, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announces...
-
Vancouver, B.C., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, September 11, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is pleased to...
-
Vancouver, B.C., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, August 30, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announces...
-
Vancouver, B.C., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, August 27, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to...
-
Vancouver, B.C., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, August 14, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor...
-
Vancouver, B.C., Aug. 12, 2019 (GLOBE NEWSWIRE) -- INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today that rock icon and marketing and...
-
Vancouver, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, August 6, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon,...
-
Vancouver, British Columbia, July 25, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, July 25, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is...